These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 38743178

  • 1. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
    Mady RF, El-Temsahy MM, Issa YA, Zaghloul AS, Khedr SI.
    Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
    [Abstract] [Full Text] [Related]

  • 2. Plasma microRNAs are promising novel biomarkers for the early detection of Toxoplasma gondii infection.
    Jia B, Chang Z, Wei X, Lu H, Yin J, Jiang N, Chen Q.
    Parasit Vectors; 2014 Sep 08; 7():433. PubMed ID: 25199527
    [Abstract] [Full Text] [Related]

  • 3. microRNA-155 Expression and Butyrylcholinesterase Activity in the Liver Tissue of Mice Infected with Toxoplasma gondii (Avirulent and Virulent Strains).
    El-Sayad M, Abdel Rahman M, Hussein N, Abdel Aziz R, El-Taweel HA, Abd El-Latif N.
    Acta Parasitol; 2021 Dec 08; 66(4):1167-1176. PubMed ID: 33840057
    [Abstract] [Full Text] [Related]

  • 4. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model.
    Abdel-Wahab AA, Shafey DA, Selim SM, Sharaf SA, Mohsen KK, Allam DM, Elkhadry SW, Gouda MA.
    Parasitol Res; 2024 Jul 24; 123(7):286. PubMed ID: 39046555
    [Abstract] [Full Text] [Related]

  • 5. Novel insights on the therapeutic effect of levamisole on the chronic toxoplasmosis in mice model.
    Zoghroban HS, Elmansory BM, Issa YA, Eltokhy AK, Abo Safia HS, El Maghraby GM, Salama AM.
    Exp Parasitol; 2023 May 24; 248():108515. PubMed ID: 36958594
    [Abstract] [Full Text] [Related]

  • 6. Effect of spiramycin versus aminoguanidine and their combined use in experimental toxoplasmosis.
    Omar M, Abaza BE, Mousa E, Ibrahim SM, Rashed HE, Farag TI.
    J Parasit Dis; 2021 Dec 24; 45(4):1014-1025. PubMed ID: 34789985
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J, Djurković-Djaković O, Nikolić A, Klun I, Bobić B.
    Int J Antimicrob Agents; 2005 Mar 24; 25(3):226-30. PubMed ID: 15737517
    [Abstract] [Full Text] [Related]

  • 8. Characterization of extracellular vesicles isolated from types I, II and III strains of Toxoplasma gondii.
    Quiarim TM, Maia MM, da Cruz AB, Taniwaki NN, Namiyama GM, Pereira-Chioccola VL.
    Acta Trop; 2021 Jul 24; 219():105915. PubMed ID: 33861971
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
    Hagras NA, Allam AF, Farag HF, Osman MM, Shalaby TI, Fawzy Hussein Mogahed NM, Tolba MM, Shehab AY.
    Exp Parasitol; 2019 Sep 24; 204():107717. PubMed ID: 31228418
    [Abstract] [Full Text] [Related]

  • 10. Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
    Chew WK, Segarra I, Ambu S, Mak JW.
    Antimicrob Agents Chemother; 2012 Apr 24; 56(4):1762-8. PubMed ID: 22271863
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of Infection Immunity Regulated by Toxoplasma gondii to Maintain Chronic Infection in the Brain.
    Hwang YS, Shin JH, Yang JP, Jung BK, Lee SH, Shin EH.
    Front Immunol; 2018 Apr 24; 9():158. PubMed ID: 29459868
    [Abstract] [Full Text] [Related]

  • 12. [Investigation of combined effectiveness of spiramycin and beta-glucan in mice models of acute toxoplasmosis and determination of IL-10, IL-12 and TNF-α levels].
    Büyükbaba Boral O, Sönmez Tamer G, Keçeli Özcan S, Sönmez N, Işsever H, Tekeli F.
    Mikrobiyol Bul; 2012 Jul 24; 46(3):446-55. PubMed ID: 22951656
    [Abstract] [Full Text] [Related]

  • 13. Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen.
    Kim MJ, Mao J, Kang HJ, Chu KB, Quan FS.
    Korean J Parasitol; 2021 Dec 24; 59(6):565-572. PubMed ID: 34974663
    [Abstract] [Full Text] [Related]

  • 14. [Studies on the therapeutics of experimental toxoplasmosis. I. Effect of acetylspiramycin and spiramycin on the intracardiac Toxoplasma multiplication in mice infected with Toxoplasma gondii (author's transl)].
    Espinas FM, Odakura Y, Suzuki N, Sasaki H.
    Jpn J Antibiot; 1981 Aug 24; 34(8):1141-7. PubMed ID: 7321193
    [Abstract] [Full Text] [Related]

  • 15. Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1/2 expression.
    Angeloni MB, Guirelli PM, Franco PS, Barbosa BF, Gomes AO, Castro AS, Silva NM, Martins-Filho OA, Mineo TW, Silva DA, Mineo JR, Ferro EA.
    Placenta; 2013 Nov 24; 34(11):973-82. PubMed ID: 24074900
    [Abstract] [Full Text] [Related]

  • 16. A multimodality therapeutic application on Toxoplasma gondii encephalitis utilizing Spiramycin and 'de novo' Ferula asafetida in immunodeficient mice.
    Almurshidi BH, Fahmy Z, El-Shennawy A, Selim EAH, Hammam OA, Okasha H, Al-Hajj W, Mahmoud SA, Abuelenain GL.
    Parasite Immunol; 2023 Dec 24; 45(12):e13014. PubMed ID: 37807942
    [Abstract] [Full Text] [Related]

  • 17. The effect of Nigella sativa oil- and wheat germ oil-loaded metal organic frameworks on chronic murine toxoplasmosis.
    Mohammad OS, El Naggar HM, Abdelmaksoud HF, Barakat AM, Abdelhameed RM, Shehata MAS.
    Acta Trop; 2023 Mar 24; 239():106823. PubMed ID: 36608751
    [Abstract] [Full Text] [Related]

  • 18. Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.
    Etewa SE, El-Maaty DAA, Hamza RS, Metwaly AS, Sarhan MH, Abdel-Rahman SA, Fathy GM, El-Shafey MA.
    J Parasit Dis; 2018 Mar 24; 42(1):102-113. PubMed ID: 29491568
    [Abstract] [Full Text] [Related]

  • 19. Sex dichotomy in the course of experimental latent toxoplasmosis.
    Hegazy MM, Elmehankar MS, Azab MS, El-Tantawy NL, Abdel-Aziz A.
    Exp Parasitol; 2019 Jul 24; 202():15-21. PubMed ID: 31078550
    [Abstract] [Full Text] [Related]

  • 20. Genome-wide comparative analysis revealed significant transcriptome changes in mice after Toxoplasma gondii infection.
    Jia B, Lu H, Liu Q, Yin J, Jiang N, Chen Q.
    Parasit Vectors; 2013 Jun 04; 6():161. PubMed ID: 23734932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.